ES2174840T3 - Sales de un derivado de glucopiranosa y productos intermedios. - Google Patents

Sales de un derivado de glucopiranosa y productos intermedios.

Info

Publication number
ES2174840T3
ES2174840T3 ES93101202T ES93101202T ES2174840T3 ES 2174840 T3 ES2174840 T3 ES 2174840T3 ES 93101202 T ES93101202 T ES 93101202T ES 93101202 T ES93101202 T ES 93101202T ES 2174840 T3 ES2174840 T3 ES 2174840T3
Authority
ES
Spain
Prior art keywords
formula
chem
derivative
compound
glucopiranose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93101202T
Other languages
English (en)
Inventor
Katsuhiro Imaki
Shinsuke Hashimoto
Hirohisa Wakatsuka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2174840T3 publication Critical patent/ES2174840T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

UNA SAL DE DERIVADOS GLUCOPIRANOSA DE LA FORMULA (I) DONDE R2 ES R3 ES Y+ ES ION SODIO O ION TRIS(HIDROXIMETIL)METILAMONIO. ADEMAS UN DERIVADO GLUCOPIRANOSA DE LA FORMULA (II) DONDE TODOS LOS SIMBOLOS TIENEN LA MISMA SIGNIFICACION QUE SE HA DEFINIDO ANTERIORMENTE, SIENDO UN PRODUCTO INTERMEDIO IMPORTANTE PARA LA PREPARACION DE COMPUESTOS DE LA FORMULA (I). EL COMPUESTO DE LA FORMULA (I) SE DESTACA POR ACTIVIDAD SOBRESALIENTE EN INMUNIDAD CELULAR, Y POR TANTO PUEDE SER USADO PARA AGENTE DE REFORZAMIENTO DE INMUNIDAD, PROCESOS DE INDUCCION DE ACTIVIDAD DE TNF, INDUCIENDO ACTIVIDAD DE IL-1 E INDUCIENDO ACTIVIDAD DE IFN, POR CONSIGUIENTE PARA SE UTILIZADO COMO AGENTE ANTITUMORAL. ADEMAS, EL COMPUESTO DE LA FORMULA (II) ES UN PRODUCTO INTERMEDIO PARA LA PREPARACION DE COMPUESTOS DE LA FORMULA (I) Y PUEDE SER PREPARADO DE FORMA VENTAJOSA EN PROCESOS INDUSTRIALES.
ES93101202T 1992-01-31 1993-01-27 Sales de un derivado de glucopiranosa y productos intermedios. Expired - Lifetime ES2174840T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4218592 1992-01-31
JP15591392 1992-05-22

Publications (1)

Publication Number Publication Date
ES2174840T3 true ES2174840T3 (es) 2002-11-16

Family

ID=26381833

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93101202T Expired - Lifetime ES2174840T3 (es) 1992-01-31 1993-01-27 Sales de un derivado de glucopiranosa y productos intermedios.

Country Status (11)

Country Link
US (2) US5294723A (es)
EP (1) EP0553786B1 (es)
JP (2) JP2657752B2 (es)
KR (1) KR0168876B1 (es)
AT (1) ATE216393T1 (es)
CA (1) CA2088128C (es)
DE (1) DE69331814T2 (es)
DK (1) DK0553786T3 (es)
ES (1) ES2174840T3 (es)
PT (1) PT553786E (es)
TW (1) TW301653B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3057226B2 (ja) 1997-10-09 2000-06-26 琉球大学長 グルコピラノース誘導体を有効成分とするリーシュマニア症治療剤
EP1088553A4 (en) * 1998-05-06 2002-01-30 Ono Pharmaceutical Co IMMUNOSUPPRESSOR CONTAINING GLUCOPYRANOSIS DERIVATIVE AS ACTIVE INGREDIENT
JP2020152674A (ja) * 2019-03-20 2020-09-24 株式会社リコー 難水溶性化合物の可溶化物の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2635985A1 (de) * 1976-08-06 1978-02-09 Schering Ag Prostansaeurederivat und verfahren zu ihrer herstellung
JPS63179885A (ja) * 1985-12-06 1988-07-23 Ono Pharmaceut Co Ltd 新規なグリコピラノース誘導体
US4925929A (en) * 1985-12-06 1990-05-15 Ono Pharmaceutical Co. Ltd. Glucopyranose derivatives
ES2032386T3 (es) * 1985-12-06 1993-02-16 Ono Pharmaceutical Co., Ltd. Un procedimiento para la preparacion de un derivado de glucopiranosa.

Also Published As

Publication number Publication date
CA2088128A1 (en) 1993-08-01
EP0553786A2 (en) 1993-08-04
KR930016434A (ko) 1993-08-26
KR0168876B1 (ko) 1999-01-15
DK0553786T3 (da) 2002-08-12
PT553786E (pt) 2002-08-30
DE69331814D1 (de) 2002-05-23
EP0553786B1 (en) 2002-04-17
US5733927A (en) 1998-03-31
JPH0641175A (ja) 1994-02-15
TW301653B (es) 1997-04-01
JP2906228B2 (ja) 1999-06-14
US5294723A (en) 1994-03-15
ATE216393T1 (de) 2002-05-15
DE69331814T2 (de) 2002-11-28
EP0553786A3 (en) 1996-03-13
CA2088128C (en) 2002-10-29
JP2657752B2 (ja) 1997-09-24
JPH09194495A (ja) 1997-07-29

Similar Documents

Publication Publication Date Title
FR2372803A1 (fr) Derives acyles substitues d'amino-acides, a activite anti-hypertensive
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
DK165453C (da) Fremgangsmaade til fremstilling af 2'-desoxyadenosinforbindelser
ES2031569T3 (es) Derivados de acidos quinolinocarboxilicos.
OA09016A (fr) Produits cathartiques.
NZ248099A (en) Use of spiro-oxathiolane quinuclidine derivatives for treating sjoegren syndrome
SE9003476L (sv) Novel isoindole derivatives and salts thereof, process for producing the same and antitumor agent comprising the same
ES8507498A1 (es) Un procedimiento para la preparacion de acidos fenilquinolin-carboxilicos.
ES2174840T3 (es) Sales de un derivado de glucopiranosa y productos intermedios.
ES431497A1 (es) Procedimiento para preparar un derivado de s-triazol (1,5- a) piridina.
DE3881862T2 (de) Disaccharidderivate.
ES2044900T3 (es) Un proceso para la preparacion de un derivado de antraciclina.
ATE146481T1 (de) Epoxysuccinamidsäurederivat
IT1214595B (it) Procedimento di trattamento disoluzioni uranifere acide mediante addizione di un sale di alluminio.
IT1106279B (it) Procedimento per depurare soluzioni acquose di alogenuri alcalini per l'elettrolisi
DE3564577D1 (de) 7-d-mandelamido-3-(1-sulfomethyltetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid monosodium salt
TW198713B (es)
TNSN89109A1 (fr) Procede de preparation de nouveaux derives de la methoxycarbonyl-2 n,n'-di (trimethoxybenzoyle) piperazine
FR2368495A1 (fr) Procede de preparation d'acides 2-carbamoylphosphiniques n-substitues
ATE72443T1 (de) Glucopyranose-derivate.
ES2058253T3 (es) Metodo para producir derivados de indano.
ES8402285A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-bencil-4-(4-(2-pirimidinilamino)bencil)-2,3-dioxopiperazina o sus sales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 553786

Country of ref document: ES